Nutritional significance of lectins and enzyme inhibitors from legumes.
Level 5 - mechanism / opinion, no new human data
Narrative review of biochemical mechanisms and nutritional literature without systematic trial synthesis.
PubMed 12381157 · doi:10.1021/jf020191k
What was done
The author reviewed the nutritional, antinutritional, and pharmacological roles of legume components, specifically lectins, alpha-amylase inhibitors, and protease (trypsin and chymotrypsin) inhibitors, focusing on processing-induced inactivation and impacts on protein digestibility.
What was found
The abstract reports no numerical data. It notes that adequate processing inactivates antinutritional factors to levels where chronic residual ingestion is unlikely to pose human health risks. It also identifies that these compounds can inhibit specific digestive enzymes (trypsin, chymotrypsin, disaccharidases, alpha-amylases), bind glycoconjugates, enter systemic circulation, and potentially reduce cancer risk, though high contents reduce overall legume protein digestibility.
Why it matters
It frames legume antinutrients not solely as dietary deterrents that require thermal inactivation, but also as bioactive molecules with potential therapeutic and pharmacological value.
Limits
The abstract lacks quantitative outcomes, systematic methodology, sample sizes, and clinical trial evidence. It relies on generalized narrative and mechanistic assertions.
Cited by
- context Unless plant-based foods like legumes and grains are soaked, sprouted, or fermented, amino acid bioavailability is reduced and they can cause gut irritation.